Ro vs Noom Med: GLP-1 Weight Loss Programs Compared (2026)
An independent, side-by-side comparison of Ro and Noom for GLP-1 weight loss programs — pricing, medications, protocols, and patient experience.

Quick Verdict
Best Price
Ro
Starting at $149/mo vs $199/mo
Most Medications
Ro
2 medications vs 2
Best for Beginners
Ro
Async Telehealth, fast onboarding
Head-to-Head Comparison
Pricing Breakdown
Side-by-side pricing for every medication.
| Medication | Ro | Noom | Savings |
|---|---|---|---|
| Semaglutide | $149/monthly | $199/monthly | Save $50/mo with Ro |
| Tirzepatide | $299/monthly | Not offered | Only at Ro |
Pros and Cons
Ro
- Competitive compounded semaglutide pricing (from $149/mo)
- Large established platform with millions of patients
- Free ongoing provider messaging
- Body program includes metabolic health coaching
- No video consultations — async only
- No lab testing included
- Only offers GLP-1 weight loss medications
- Compounded medications not FDA-approved as finished products
Noom
- Unique combination of GLP-1 medication with an established CBT-based behavior-change curriculum
- Video consultations required (more thorough clinical evaluation than async providers)
- Over a decade of behavior-change coaching experience predating the medication program
- Personal coach and group coaching included in the price
- Competitive compounded semaglutide pricing ($149/month) for what's included
- Cannot opt out of the coaching/app component to lower cost
- Noom Med is relatively new (launched 2023)
- No published clinical trial data specifically for the combined Med + coaching program
- No lab testing included
- Pricing has been volatile
How They Compare
Our editorial assessment across key dimensions.
In-Depth Comparison
By sarah-chen · Last updated April 14, 2026
Ro vs Noom Med: GLP-1 Programs Compared
Both Ro and Noom Med offer compounded semaglutide at $149/month — but they represent opposite philosophies about what a GLP-1 program should be. Ro is fast, lean, and medication-forward. Noom is behavioral-first, with an app built around changing the psychological relationship with food and eating. Here is how they compare on every dimension that matters.
Quick Verdict
| Ro | Noom Med | |
|---|---|---|
| Monthly cost | $149/month | $149/month (medication included) |
| Best for | Speed, simplicity, tirzepatide access | Behavioral change alongside medication |
| Weakest point | Thin coaching layer | App-heavy; some find it tedious |
| Tirzepatide available? | Yes | No (semaglutide only) |
| Start time | 4–7 days | 7–14 days |
| Insurance navigation | No | No |
Pricing and What's Included
| Feature | Ro | Noom Med |
|---|---|---|
| Monthly fee | $149 | $149 |
| Medication included | Yes (compounded semaglutide or tirzepatide) | Yes (compounded semaglutide) |
| Initial medical evaluation | Included | Included |
| Ongoing provider check-ins | Async (message-based) | Async + in-app curriculum |
| Behavioral app | Limited | Full Noom app (CBT-based curriculum) |
| Nutrition coaching | Basic guidance | Structured program |
| Lab work | Not included | Not included |
| Cancellation | Cancel anytime | Cancel anytime |
Price parity is real — both platforms land at $149/month for semaglutide. The difference is what $149 buys you beyond the medication.
Medication Options
| Ro | Noom Med | |
|---|---|---|
| Compounded semaglutide | Yes | Yes |
| Brand-name Wegovy | No (not supported) | No |
| Tirzepatide (compounded) | Yes — key differentiator | No |
| Oral GLP-1 (orforglipron) | Pending | Pending |
Ro's tirzepatide access is a meaningful differentiator. Tirzepatide (dual GIP/GLP-1) consistently produces ~5 additional percentage points of average weight loss vs semaglutide in head-to-head comparisons. If tirzepatide is your target medication, Ro is the platform.
The Program Philosophy Divide
Ro: Medication-Forward
Ro's Body program is built around frictionless access to GLP-1 medications with medical oversight. The value proposition is simple: get a prescription quickly, receive the medication by mail, and check in asynchronously with a provider. There is no required app curriculum, no behavioral modules to complete before your next refill ships.
Who thrives here: Patients who understand GLP-1 mechanics, have strong self-direction, and want medication without a required behavioral program attached.
Noom Med: Behavioral-Forward
Noom built its reputation as a behavioral change app before it added medication. Noom Med layers semaglutide onto Noom's existing cognitive behavioral therapy (CBT)-based curriculum. The program explicitly positions the medication as a tool to lower appetite noise while the behavioral curriculum builds new habits.
The theory: GLP-1 medications work best when patients also change their relationship to hunger, food decisions, and emotional eating. Medication handles the pharmacology; the app addresses the psychology.
Who thrives here: Patients who want structured behavioral support alongside their medication, who find the psychological dimensions of weight management as important as the physiological ones, and who are willing to engage with app-based content.
Coaching and Support
| Feature | Ro | Noom Med |
|---|---|---|
| Human coach access | Medical provider (async) | Noom coach + medical provider |
| Coaching style | Medical check-ins | Behavioral + nutritional coaching |
| Response time | 24–48 hours | 24–48 hours |
| Curriculum | None required | Structured daily curriculum |
| Community features | Limited | Group support available |
The honest trade-off: Noom's coaching is broader but the app-based delivery requires engagement. Patients who bounce off app ecosystems won't extract its value. Ro's lighter touch works well for patients who don't need behavioral scaffolding.
Speed to Treatment
| Step | Ro | Noom Med |
|---|---|---|
| Online intake | 10 minutes | 15–20 minutes |
| Medical review | Same day – 24 hours | 24–48 hours |
| Prescription approval | Fast | Moderate |
| Shipping time | 3–5 days | 5–10 days |
| Total: first dose | ~4–7 days | ~7–14 days |
Ro is faster. If speed to first dose matters, Ro has the edge.
What the Evidence Says About Behavioral Programs
Noom's behavioral approach has a logic backed by research: behavioral interventions improve GLP-1 outcomes, and patients who combine medication with lifestyle changes maintain more weight loss after stopping. However, app completion rates in behavioral programs are variable, and not all patients engage with the curriculum consistently.
Clinical context: The STEP-1 and SURMOUNT-1 trials that established GLP-1 efficacy included counseling alongside medication — which suggests the behavioral component has additive value. Whether Noom's CBT app delivers equivalent value to clinical counseling is a separate question.
Head-to-Head: Who Should Choose Which
Choose Ro if:
- You want tirzepatide rather than semaglutide
- You want the fastest path to your first prescription
- You prefer minimal required engagement beyond medical check-ins
- You've already done behavioral work and need medication support
- You may switch to brand-name or higher-dose medications later
Choose Noom Med if:
- Behavioral change is as important to you as the medication
- You've tried medication alone before without sustained results
- You want structured daily curriculum to build habits around the medication
- You find accountability and goal-tracking helpful for adherence
- Tirzepatide is not a priority
Alternatives to Consider
| Provider | Why Consider | Monthly Cost |
|---|---|---|
| Henry Meds | Fastest start (4–7 days), tirzepatide available, $129/month after 6 months | $149 |
| Found | Behavioral + non-GLP-1 medication options; broad treatment menu | $99+ |
| Calibrate | Deep coaching (RD + behavioral health), full year curriculum | $249+ |
| FORM Health | Board-certified obesity medicine; insurance navigation | $149+ |
Related Resources
- Best GLP-1 with Coaching — programs ranked by coaching depth
- Henry Meds vs Noom Med — Noom's closest price competitor
- Best Tirzepatide Providers — if tirzepatide is your target
- How Much Weight Can You Lose on GLP-1 — realistic expectations
- GLP-1 Cost Guide — pricing breakdown across all options
Related Guides
Aleniglipron: Structure Therapeutics' Oral GLP-1 — What Patients Need to Know
Complete guide to aleniglipron, Structure Therapeutics' investigational oral GLP-1 showing 16.3% placebo-adjusted weight loss at 44 weeks in Phase 2 ACCESS II — the highest weight loss reported for any oral GLP-1 to date. Only 3.7% discontinuation rate. Phase 3 expected H2 2026, with earliest FDA approval in 2028 or later.
Read guide →Best GLP-1 Options After Foundayo Approval: Oral vs Injectable 2026
Read guide →Best GLP-1 Weight Loss Programs 2026: Every Major Provider Ranked
Every major GLP-1 weight loss program ranked — real pricing, clinical models, and honest assessments. No provider paid for placement.
Read guide →